Aytu BioPharma to Be Acquired by Rosemont Pharmaceuticals Holdings for $2.70 Per Share in Cash
What happened
Aytu BioPharma entered into a definitive merger agreement to be acquired by Rosemont Pharmaceuticals Holdings, Inc. via a tender offer for $2.70 per share in cash.
Source
Extracted by Autobound
From the Signal API record- Signal
- SEC 8-K
What this signalsFilings often name leadership changes, deals and spending plans.
- Form
- 8-K
- Filed
- Nov 16, 2026
More from Aytu BioPharma, Inc.
More SEC 8-K signals at other companies
- SEC 8-KAclaris Therapeutics, Inc.Aclaris Initiates Phase 2b ALPHA Trial of Modzatinib in Moderate-to-Severe Lichen PlanusSEC 8-K
- SEC 8-KAirjoule Technologies CorporationTimothy N. White Appointed to Board of Directors Succeeding Ajay Agrawal Effective November 12, 2026SEC 8-K
- SEC 8-KAMC Robotics CorporationRecorded $0.25 million non-recurring inventory impairment associated with Vietnam supply chain relocationSEC 8-K
The full record
From the Signal API recordDetails
- CIK
- 1385818
- Accession number
- 0001437749-26-037155
- Metric named
- $2.70 per Share net in cash
- Timeframe
- Immediate
- Filing year
- 2026
- Why it matters
- Integration needs coming
- Signal category
- Strategic
- Event
- acquisitionAnnounced
Topics and mentions
Events in the filing
- Acquisition announced
Tags
- acquisitionAnnounced
Extraction
- Confidence
- High
- Relevance
- 95%
- Sentiment
- Positive
- Detected
- Nov 17, 2026
- signal_type
sec-8k- signal_subtype
acquisitionAnnounced
Use this data
Get every SEC 8-K signal for Aytu BioPharma, Inc. and the companies you sell to, in the tools you already use.
Ask Claude about it
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Aytu BioPharma, Inc. this week?”
Send it to your own tools
The Signal API returns SEC 8-K signals for any list of companies as JSON, for your CRM, warehouse or app.
Try it free
Sign up and spend your free credits on the companies you sell to.
Start Free1,000 free credits
The API returns more than this page shows
This page shows a preview. The full sec-8k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the API
Signal
signal_nameValue in the APIassociationValue in the API
Show the full JSONHide the full JSONThe record on this page and the API request
GET /v1/signals/3d061e82-b664-4c53-b1bd-273bb52cf64e returns this record as JSON. POST /v1/companies/enrich returns every signal for aytubio.com.
{
"signal_id": "3d061e82-b664-4c53-b1bd-273bb52cf64e",
"signal_type": "sec-8k",
"signal_subtype": "acquisitionAnnounced",
"detected_at": "2026-11-17T07:03:14.626+00:00",
"company": {
"name": "Aytu BioPharma, Inc.",
"domain": "aytubio.com"
},
"data": {
"detail": "Aytu BioPharma entered into a definitive merger agreement to be acquired by Rosemont Pharmaceuticals Holdings, Inc. via a tender offer for $2.70 per share in cash. For sellers: Change-of-control transactions frequently trigger organizational restructuring and integration reviews of systems and vendor contracts.",
"metrics": {
"timeframe": "immediate",
"dollar_context": "$2.70 per Share net in cash"
},
"summary": "Aytu BioPharma to Be Acquired by Rosemont Pharmaceuticals Holdings for $2.70 Per Share in Cash",
"relevance": 0.95,
"sentiment": "positive",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/1385818/000143774926037155/aytu20261113_8k.htm",
"filing_date": "2026-11-16",
"filing_year": 2026,
"sales_relevance": "Integration needs coming",
"signal_category": "strategic"
}
}
curl https://signals.autobound.ai/v1/signals/3d061e82-b664-4c53-b1bd-273bb52cf64e \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"aytubio.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.